Neurocrine Biosciences, Inc.
METHODS FOR THE ADMINISTRATION OF CERTAIN VMAT2 INHIBITORS
Last updated:
Abstract:
Provided is a method of administering a vesicular monoamine transporter 2 (VMAT2) inhibitor to a subject in need thereof, wherein the subject has severe renal impairment.
Status:
Application
Type:
Utility
Filling date:
10 Aug 2020
Issue date:
25 Feb 2021